EEFSEC p.Pro180Leu
c.539C>T · rs369240402 · VCV3087348
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1124 | likely benign |
|---|---|---|
| REVEL | 0.672 | pathogenic-leaning |
| SaProt | LLR -11.50 | damaging |
| ⇒ REVEL and SaProt call this damaging; AlphaMissense does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 2.3, phastCons 1 |
| Regional constraint | o/e 0.93 | unconstrained · MANE · 255 kb · p 0.039 · regional, not allelic |
| Overall | ||
| CADD | 27.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0547% | 1,829 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,508 |
| European (non-Finnish) | 0.000763% | 131,112 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EEFSEC
- Protein
- p.Pro180Leu
- Coding
- c.539C>T
- MANE Select
- NM_021937
- dbSNP
- rs369240402
- Type
- single nucleotide variant
- Location
- chr3:128262142 (GRCh38)
- Gene constraint
- LOEUF 1.345 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 79.98 · 4 PDB
- Residue 180
- the tr-type g domain
Similar variants
- EEFSEC p.Pro180= Benign ★★ same residue
- EEFSEC p.Arg285Gln Uncertain significance ★★ ⚠ same type
- EEFSEC p.Arg424Gln Uncertain significance ★★ ⚠ same type
- EEFSEC p.Phe463Leu Uncertain significance ★★ ⚠ same type
- EEFSEC p.Ala435Val Benign ★★ same type
- EEFSEC p.Phe581Cys Benign ★★ same type
- EEFSEC p.Asp390Ala Likely pathogenic ★ ⚠ same type
- EEFSEC p.Glu514Ter Likely pathogenic ★ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/eefsec-p-pro180leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown